Jeličić, M.-L.; Brusač, E.; Kurajica, S.; Cvetnić, M.; Amidžić Klarić, D.; Nigović, B.; Mornar, A.
Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools. Pharmaceutics 2021, 13, 400.
https://doi.org/10.3390/pharmaceutics13030400
AMA Style
Jeličić M-L, Brusač E, Kurajica S, Cvetnić M, Amidžić Klarić D, Nigović B, Mornar A.
Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools. Pharmaceutics. 2021; 13(3):400.
https://doi.org/10.3390/pharmaceutics13030400
Chicago/Turabian Style
Jeličić, Mario-Livio, Edvin Brusač, Stanislav Kurajica, Matija Cvetnić, Daniela Amidžić Klarić, Biljana Nigović, and Ana Mornar.
2021. "Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools" Pharmaceutics 13, no. 3: 400.
https://doi.org/10.3390/pharmaceutics13030400
APA Style
Jeličić, M. -L., Brusač, E., Kurajica, S., Cvetnić, M., Amidžić Klarić, D., Nigović, B., & Mornar, A.
(2021). Drug–Drug Compatibility Evaluation of Sulfasalazine and Folic Acid for Fixed-Dose Combination Development Using Various Analytical Tools. Pharmaceutics, 13(3), 400.
https://doi.org/10.3390/pharmaceutics13030400